Gender-Age Distribution of Patients with COVID-19 at Different Stages of Epidemic in Moscow

The ongoing COVID-19 pandemic around the world and in Russia remains a major event of 2020 All over the world, research is being conducted to comprehensively study the patterns and manifestations of the epidemic process The main quantitative characteristics of SARS-CoV-2 transmission dynamics among the population, based on the data of official monitoring over the current situation, play an important role in the development of the epidemiological surveillance system The aim of this study is to explore the peculiarities of age-gender distribution of COVID-19 patients in Moscow Material and methods The data related to the epidemiological characteristics of age-gender structure of COVID-19 patients in Moscow between March 19, 2020 and April 15, 2020, at different stages of the epidemic were retrospectively analyzed Results and discussion The mean age of COVID-19 patients in Moscow was 46,41±20,58 years The gender ratio (male/female) among the patients was 52 7/47 3 %, wherein the indicators varied depending upon the age Male/female ratio in the age group “under 39” stood at 53 7/46 3 %, and “over 40 years of age” – at 39 3/60 7 % The predominant age range among male cases was 19 to 39 years old – 35 4 %, while among female patients – 40–59 years (36 5 %) The age distribution of patients in Moscow is indicative of the fact that COVID-19 is a disease that primarily affects older age groups The age structure of all COVID-19 cases during the observation period is characterized by predominance of adult patients over 19 years of age – 92,7 % (92,6–92,8 %), the share of patients aged 40–59 years is 35,7% (35,5–35,9 %) The differences in the age distribution in males and females are as follows: in the male cohort, the age groups 19–39 years old and 40–59 years old prevail – 35 4 % (35 1–35 7 %) and 34 9 % (34 6–35 2 %), respectively The age group 40–59 years old – 36 5 % (36 3–36 8%) dominates in the female cohort © 2020 Russian Research Anti-Plague Institute All rights reserved